跳转至内容
Merck
CN

Y0000165

Tribenoside

European Pharmacopoeia (EP) Reference Standard

别名:

Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C29H34O6
化学文摘社编号:
分子量:
478.58
UNSPSC Code:
41116107
EC Number:
233-687-2
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

O1[C@@H]([C@@H]([C@H](C1OCC)O)OCc4ccccc4)C(OCc3ccccc3)COCc2ccccc2

InChI key

ULLNJSBQMBKOJH-NUZMXOBKSA-N

InChI

1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1

grade

pharmaceutical primary standard

API family

tribenoside

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

shipped in

wet ice

storage temp.

−20°C

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

存储类别

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yamato Kikkawa et al.
Biological & pharmaceutical bulletin, 33(2), 307-310 (2010-02-02)
Tribenoside has been used clinically for hemorrhoidal disease associated with coagulation, inflammation, and wounds. However, the pharmacological mechanism of tribenoside activity has never been clear. In this study we examined whether tribenoside affected expression and deposition of laminins that are
G M Iakovlev et al.
Vestnik khirurgii imeni I. I. Grekova, 126(2), 71-76 (1981-02-01)
The investigation of the peripheral circulation by using the all-purpose occlusion rheoplethysmography enables the reaction of rising the venous tone in response to the action exerted by the tissue ischemia products to be quantitatively estimated along with a one-time determination
A Sioufi et al.
Journal of pharmaceutical sciences, 69(2), 167-169 (1980-02-01)
The determination of alpha-tribenoside at concentrations down to 10 ng/ml and beta-tribenoside at concentrations down to 5 ng/ml in human plasma is described. After addition of an internal standard, alpha- and beta-tribenosides are extracted at basic pH into benzene. Both
D A Kalbhen
Zeitschrift fur Rheumatologie, 42(4), 187-194 (1983-07-01)
Due to their pharmacological properties most antiphlogistic/antirheumatic drugs are successfully used for treatment of inflammatory rheumatic diseases, but they are not able to counteract cartilage degeneration in osteoarthrosis. For specific therapy of osteoarthrosis only those drugs are suitable, which are
[Centella asiatica extract in venous pathology of the lower limbs and its evaluation as compared with tribenoside].
F Marastoni et al.
Minerva cardioangiologica, 30(4), 201-207 (1982-04-01)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持